Warren Mason
University of Toronto
H-index: 68
North America-Canada
Top articles of Warren Mason
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults | Christopher Hahn Adrian Budhram Katayoun Alikhani Nasser AlOhaly Grayson Beecher | 2024 | |
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma | Neuro-Oncology Advances | Matthijs van der Meulen Ronald C Ramos Mathew R Voisin Vikas Patil Qingxia Wei | 2024/1/1 |
A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life … | Katherine Peters Ingo Mellinghoff Martin Van Den Bent Deborah Blumenthal Mehdi Touat | 2024/4/14 | |
Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial | Neuro-oncology | Patrick Roth Thierry Gorlia Jaap C Reijneveld Filip de Vos Ahmed Idbaih | 2024/3/19 |
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma | Molecular cancer therapeutics | Cha Len Lee Grainne M O'Kane Warren P Mason Wen-Jiang Zhang Pavlina Spiliopoulou | 2024/3/1 |
Trametinib for Painful Glomus Tumors in a Patient with Neurofibromatosis Type 1 | Canadian Journal of Neurological Sciences | Seth A Climans Ronald C Ramos Dimitri J Anastakis Warren P Mason | 2023/5 |
ACQUIRED PTEN LOSS MAY MEDIATE DABRAFENIB AND TRAMETINIB RESISTANCE IN BRAF V600E–MUTATED EPITHELIOID GLIOBLASTOMA: A CASE REPORT | Neuro-Oncology Advances | Abrar Ahmed Liana Nobre Warren Mason Julie Bennett Uri Tabori | 2023/7 |
CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL | Neuro-Oncology | Farshad Nassiri Vikas Patil Leeor Yefet Olivia Singh Jeff Liu | 2023/11/1 |
Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival | Neuro-Oncology Practice | Marissa Sherwood Seth Climans Ronald Ramos Normand J Laperriere Andrew F Gao | 2023/4/1 |
THE CLINICAL AND MOLECULAR LANDSCAPE OF GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS | Neuro-Oncology Advances | J Bennett L Nobre J Sheth S Ryall K Fang | 2023/7 |
498O INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma | Annals of Oncology | D Blumenthal IK Mellinghoff MJ van den Bent M Touat K Peters | 2023/10/1 |
LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR IDH2 DIFFUSE GLIOMA TUMOR GROWTH RATE: RESULTS FROM THE … | Neuro-Oncology | Patrick Wen Ingo Mellinghoff Martin van den Bent Deborah Blumenthal Mehdi Touat | 2023/11/1 |
Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma | Neuro-Oncology Practice | Angela Sekely Lori J Bernstein Kristin L Campbell Warren P Mason Normand Laperriere | 2023/2/1 |
BRAF Mutations in CNS Tumors—Prognostic Markers and Therapeutic Targets | Thiago P Muniz Warren P Mason | 2023/7 | |
INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION | Catherine McBain Ingo K Mellinghoff Martin J van den Bent Deborah T Blumenthal Mehdi Touat | 2023/10/1 | |
INNV-26. THE CHALLENGE OF TREATING ADULTS WITH MEDULLOBLASTOMA–THE CANON EXPERIENCE | Neuro-Oncology | Julie Bennett Mary-Jane Lim-Fat Katrina Roberto Natalie Massey Vijay Ramaswamy | 2023/11/1 |
Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 Mutations | Journal of Clinical Oncology | Warren P Mason | 2023/1/20 |
Bevacizumab for cerebral radionecrosis: a single-center experience | Canadian Journal of Neurological Sciences | Seth A Climans Ronald C Ramos Paola A Jablonska David B Shultz Warren P Mason | 2023/7 |
Bispecific T-cell engagers and chimeric antigen receptor T-cell therapies in glioblastoma: an update | Roa Alsajjan Warren P Mason | 2023/9/15 | |
QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2DIFFUSE GLIOMA (INDIGO … | Neuro-Oncology | Katherine Peters Ingo Mellinghoff Martin van den Bent Deborah Blumenthal Mehdi Touat | 2023/11/1 |
Co-Authors
